2014

January:

Due to its practical exploration in promoting the development of the ethnic medicine industry and providing sustained support to Tibetan areas through long-term mechanisms, it was selected as a “2013 Global Compact China Best Practice Case.”

Selected for the Top 100 Chinese Listed Companies with Growth Potential on Forbes’ “China’s Most Promising Small and Medium-Sized Enterprises List.”

February:

Ms. Lei Jufang, Chairwoman of the company, has been listed on the “Top 100 Chinese Financial and Intellectual Leaders of 2013.”

April:

Gansu Qizheng Tibetan Medicine Co., Ltd., a subsidiary of the company, has completed technological upgrades and commenced production, and has obtained GMP certification for plaster (rubber-based plasters) and ointments.

The company has been honored with the title of “Top 100 Most Influential Enterprises in China’s Pharmaceutical Industry 2013.”

Ms. Lei Jufang, Chairperson of the company, has been honored with the title of “Top Ten Leading Figures on the 2013 China Pharmaceutical Industry’s Most Influential List.”

May:

The company actively participated in the “Xinyang Trip” and “Southern Xinjiang Trip” events organized by China’s Guangcai Cause, donating to support local public welfare initiatives and receiving a donation certificate jointly awarded by the China Guangcai Cause Promotion Association and the China Guangcai Cause Foundation.

June:

At the 9th International Forum on Corporate Social Responsibility of Chinese Enterprises and the 2013 “Golden Bee CSR—China List” Awards Ceremony, the company was honored with the “Golden Bee Award—Growing Enterprise” for its sustained efforts in biodiversity conservation, becoming a pioneering role model in China’s practice of corporate social responsibility.

The company received an award from the Tibet Autonomous Region government for holding the “Qizheng & Design” well-known Chinese trademark.

Gansu Qizheng Tibetan Medicine Co., Ltd., a subsidiary of the company, has been awarded the honorary title of “A-Level Tax Credit Enterprise.”

The Southern Institute of Pharmaceutical Economics exclusively released the “2013 Top 100 Chinese Pharmaceutical Industry List,” and Qizheng Tibetan Medicine was listed among them.

July:

The pain-relieving plaster has been awarded the title of “Brand-name Product” in the Nyingchi region.

August:

The 7th “Healthy China—China Pharmaceutical Brand List,” organized by the China Pharmaceutical Retail Development Research Center (MDC), the China Pharmaceutical Enterprises Cooperation and Development Organization (CPEO), and the China Pharmaceutical Brand Evaluation Committee, has been announced, and our company’s product, Qizheng Pain-Relieving Plaster, has made the list.

The 2014 Ranking of China’s Pharmaceutical Brand Values was released, with the “Qi Zheng” brand ranking 14th with a brand value of 1.929 billion yuan.

September:

In the “2014 China Listed Companies Social Responsibility Information Disclosure Research Report,” jointly released by the China Association of Listed Companies and the Securities Times, our company stood out among the 668 A-share companies that publicly disclosed social responsibility reports, ranking seventh in the overall evaluation and earning a place among the companies rated at Level A.

The company’s wholly-owned subsidiaries, Tibet Qizheng Tibetan Medicine Marketing Co., Ltd. and Gansu Qizheng Tibetan Medicine Marketing Co., Ltd., have both passed the certification under the new GSP standards.

October:

The company’s “2013 Qizheng Pain-Relieving Plaster—Pain Relief Month Brand Integration and Communication” project won the “2014 Second China Over-the-Counter Drug Brand Communication Award—Best Contribution to Consumer Education.”

In the 2014 comprehensive statistical ranking of Chinese over-the-counter (OTC) drug products released by the China Association of Non-Prescription Drugs, the company’s product, Qizheng Xiaotong Paste, ranked third in the category of traditional Chinese medicine topical preparations.

November:

Tibet Qizheng Tibetan Medicine Marketing Co., Ltd., a subsidiary of the company, has been awarded the honors of “Tax Credit Grade A Enterprise” and “Advanced Taxpayer Unit for 2013.”

In the first-ever National Ethnic Medicine Science and Technology Awards, the company received two honors: the First Prize for Scientific and Technological Progress and the First Prize for Innovation in the Ethnic Medicine Industry.

December:

Longxi Qizheng Pharmaceutical Co., Ltd., a subsidiary of the company, has obtained certification under the new GMP standards.

Gannan Foge Tibetan Medicine Co., Ltd., a subsidiary of the company, has once again been honored with the title of “Famous Trademark of Gansu Province” for its brand “Zangling.”